D16 Pharma & Biotec Report issue

For profit Phase 4
Founded: Dhaka Bangladesh (2010)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2012
NCT01613729
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

D16 Pharma & Biotec Ltd.

Active Ingredients

Drugs in Phase 4 Trials (1)

rosuvastatin (crestor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyslipidemias (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1